Boehringer Ingelheim Press Releases

Press Release Subscription: Signup here to the Boehringer Ingelheim Newsletter to receive press-releases via email.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

PRESS RELEASE

Press Release Overview

Here you can find an overview list of our recent Press Releases.

Read more Press Release Overview
PRESS RELEASE 13 Jan 2021 at 09:00

EMA marketing authorization for NexGard® COMBO for cats

Read more on EMA marketing authorization for NexGard® COMBO for cats
PRESS RELEASE 12 Jan 2021 at 10:00

Collaboration with Enara Bio on Cancer Immunotherapies

Read more on Collaboration with Enara Bio on Cancer Immunotherapies
PRESS RELEASE 12 Jan 2021 at 09:00

Boehringer Ingelheim partners with PetMedix

Read more on Boehringer Ingelheim partners with PetMedix
PRESS RELEASE 11 Jan 2021 at 10:00

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

Read more on Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
PRESS RELEASE 07 Jan 2021 at 09:00

Vaccinating with Enterisol® Ileitis reduces Salmonella in swine

Read more on Vaccinating with Enterisol® Ileitis reduces Salmonella in swine
PRESS RELEASE 18 Dec 2020 at 14:00

SARS-CoV-2 Neutralizing Antibody enters Clinical Phase

Read more on SARS-CoV-2 Neutralizing Antibody enters Clinical Phase
PRESS RELEASE 10 Dec 2020 at 14:00

Boehringer Ingelheim to acquire NBE-Therapeutics

Read more on Boehringer Ingelheim to acquire NBE-Therapeutics
PRESS RELEASE 09 Dec 2020 at 10:00

Boehringer Ingelheim to acquire Labor Dr. Merk & Kollegen

Read more on Boehringer Ingelheim to acquire Labor Dr. Merk & Kollegen
PRESS RELEASE 07 Dec 2020 at 14:00

Collaboration with Proxygen on Molecular Glue Degraders

Read more on Collaboration with Proxygen on Molecular Glue Degraders
PRESS RELEASE 07 Dec 2020 at 08:00

Boehringer Ingelheim becomes member of IPC

Read more on Boehringer Ingelheim becomes member of IPC
PRESS RELEASE 01 Dec 2020 at 10:00

Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships

Read more on Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships
PRESS RELEASE 28 Oct 2020 at 13:00

Developing potential treatment for severe COVID19 complications

Boehringer Ingelheim begins a phase 2 clinical trial of a targeted therapy to help people with severe respiratory illness from COVID-19

Read more on Developing potential treatment for severe COVID19 complications
PRESS RELEASE 27 Oct 2020 at 09:00

Partnership leads to innovative needle free injection device for pigs

Read more on Partnership leads to innovative needle free injection device for pigs
PRESS RELEASE 22 Oct 2020 at 09:00

Purevax® range now available in 0.5 ml presentation

Read more on Purevax® range now available in 0.5 ml presentation
PRESS RELEASE 14 Oct 2020 at 14:00

Expanded alliance with OBT advances cancer immunology pipeline

Read more on Expanded alliance with OBT advances cancer immunology pipeline
PRESS RELEASE 07 Oct 2020 at 09:00

Winners of the 2020 European PRRS Research Award

Read more on Winners of the 2020 European PRRS Research Award
PRESS RELEASE 05 Oct 2020 at 09:00

Study shows vaccinating results in increased milk production

Read more on Study shows vaccinating results in increased milk production
PRESS RELEASE 30 Sep 2020 at 09:00

Boehringer Ingelheim and Fraunhofer IME launch collaboration

Read more on Boehringer Ingelheim and Fraunhofer IME launch collaboration
PRESS RELEASE 29 Sep 2020 at 05:30

Boehringer Ingelheim invests in partnership to further develop the pet market in China

Read more on Boehringer Ingelheim invests in partnership to further develop the pet market in China